Skip to content
Delayed ~15 min

ORIC ORIC PHARMACEUTICALS

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · estimated

What 21 analyst firms say about ORIC PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works

8.82 USD+0.33 (+3.89%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+136.7%to the avg target 20.88 USD+12.06 USD
Buy 18 · Hold 2 · Sell 0

20 rated views · 21 analyst/firm records · 21 firms

Latest report28 Oct 2026avg report date 23 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MGood · #44 in the index86
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8062

Recent analyst activity · last 90 days

Our tracked history has 10 reports on ORIC from 8 analyst firms in the last 90 days (21 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target, 1 lowered it, 3 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Wedbush lowered its target from $17.00 (set 1 Apr 2026) to $14.00 on 27 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BenchmarkUnnamed analystBuy8 Jun 2026—
BTIGJeet MukherjeeBuy28 Oct 202626.00 USD
Cantor FitzgeraldPrakhar AgrawalBuy10 Mar 2026—
CitigroupYigal NochomovitzBuy5 May 202616.00 USD
Evercore ISICory KasimovBuy4 Aug 202625.00 USD
Goldman SachsCorinne JohnsonBuy15 May 202615.00 USD
GuggenheimMichael SchmidtBuy5 May 202618.00 USD
H.C. WainwrightRobert BurnsBuy27 Oct 202627.00 USD
JefferiesMaury RaycroftBuy5 May 202621.00 USD
JonestradingSoumit RoyBuy1 Jul 202625.00 USD
JPMorganAnupam RamaBuy14 Oct 202626.00 USD
Ladenburg ThalmannKevin M DegeeterBuy24 Feb 202615.00 USD
Leerink PartnersAsthika GoonewardeneBuy5 Oct 202626.00 USD
OppenheimerMatthew BieglerBuy24 Feb 202615.00 USD
Piper SandlerKelsey GoodwinBuy3 Aug 202622.00 USD
StifelLaura PrendergastBuy26 Oct 202618.00 USD
WedbushDavid NierengartenBuy27 Oct 202614.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Wells FargoDerek C ArchilaBuy21 Sep 202625.00 USD
Wolfe ResearchKalpit PatelHold9 Mar 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:06 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.